LL-37 KR-12 [Q5K,D9K]

General Information


DRACP ID  DRACP03965

Peptide Name   LL-37 KR-12 [Q5K,D9K]

Sequence  KRIVKRIKKFLR

Sequence Length  12

UniProt ID  P49913 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C74H137N25O13

Absent amino acids  ACDEGHMNPQSTWY

Common amino acids  K

Mass  178144

Pl  12.83

Basic residues  7

Acidic residues  0

Hydrophobic residues  5

Net charge  7

Boman Index  -4518

Hydrophobicity  -77.5

Aliphatic Index  121.67

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29430821

Title  Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15068

DRACP is developed by Dr.Zheng's team.